<Record><identifier xmlns="http://purl.org/dc/elements/1.1/">URN:NBN:SI:DOC-93A3CML5</identifier><date>1995</date><creator>Zakotnik, Branko</creator><relation>documents/doc/9/URN_NBN_SI_doc-93A3CML5_001.pdf</relation><relation>documents/doc/9/URN_NBN_SI_doc-93A3CML5_001.txt</relation><format format_type="type">article</format><format format_type="extent">Str. 42-44</format><identifier identifier_type="COBISSID">71066368</identifier><identifier identifier_type="URN">URN:NBN:SI:doc-93A3CML5</identifier><language>slv</language><publisher>Glaxo</publisher><source>Onkološki vikend</source><rights>BY-NC-ND</rights><subject language_type_id="slv">citostatiki</subject><subject language_type_id="eng">diagnostika</subject><subject language_type_id="slv">glava</subject><subject language_type_id="slv">kemoterapija</subject><subject language_type_id="slv">onkologija</subject><subject language_type_id="slv">rak (medicina)</subject><subject language_type_id="eng">therapy</subject><subject language_type_id="slv">vrat</subject><subject language_type_id="slv">Vrata</subject><subject language_type_id="slv">zdravljenje</subject><title>Kemoterapija pri karcinomu glave in vratu</title></Record>